1. Home
  2. Analysis
  3. Relapsing-remitting-multiple-sclerosis

Relapsing-remitting multiple sclerosis: treatments, associated drugs and conditions

Summary:

Relapsing-remitting multiple sclerosis: reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged.

We study 76,275 people who have Relapsing-remitting multiple sclerosis. The information that eHealthMe analyzes includes:

- Medications that treat Relapsing-remitting multiple sclerosis and their effectiveness
- 127 drugs that are associated with Relapsing-remitting multiple sclerosis


Number of reports submitted per year:

Relapsing-remitting multiple sclerosis: 76,275 reports.

Relapsing-remitting multiple sclerosis treatments and how effective are they?

All the drugs that are associated with Relapsing-remitting multiple sclerosis:

Do you take any medication?

- You can use our AI-powered tools to monitor drug safety and effectiveness.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

How we gather our data?

Healthcare data is obtained from a number of sources including the Food and Drug Administration (FDA). This information is aggregated and used to produce personalized reports that patients can reference. Browse all conditions on eHealthMe.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.